Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Rowinsky

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|April 13, 1995
Paclitaxel (taxol)E K Rowinsky, R C Donehower
Journal of the National Cancer Institute|December 18, 1991
Taxol: twenty years later, the story unfoldsE K Rowinsky, R C Donehower
Seminars in Oncology|January 13, 1998
Topotecan in combination chemotherapyE K Rowinsky, S H Kaufmann
Drug Safety|June 25, 1998
A risk-benefit assessment of irinotecan in solid tumoursL L Siu, E K Rowinsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Plasma MMPs as surrogates of BAY 12-9566S Zucker, S G Eckhardt, E K Rowinsky
Investigational New Drugs|April 9, 2001
Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinomaS Lakhanpal, R C Donehower, E K Rowinsky
Annals of Internal Medicine|May 1, 1988
Nifedipine and oncologic Raynaud phenomenonA Hantel, E K Rowinsky, R C Donehower
Cancer Treatment Reports|January 1, 1987
Sudden dyspnea occurring 24 hours after mitomycin plus etoposide combination therapyE K Rowinsky, K V Harwood, D S Ettinger
Chest|November 1, 1985
Spontaneous pneumothorax following thoracic irradiationE K Rowinsky, M D Abeloff, M D Wharam
Seminars in Oncology|August 1, 1995
Treatment of metastatic breast cancer with combination paclitaxel/cyclophosphamideM J Kennedy, R C Donehower, E K Rowinsky
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|April 13, 1995
Paclitaxel (taxol)E K Rowinsky, R C Donehower
Journal of the National Cancer Institute|December 18, 1991
Taxol: twenty years later, the story unfoldsE K Rowinsky, R C Donehower
Seminars in Oncology|January 13, 1998
Topotecan in combination chemotherapyE K Rowinsky, S H Kaufmann
Drug Safety|June 25, 1998
A risk-benefit assessment of irinotecan in solid tumoursL L Siu, E K Rowinsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Plasma MMPs as surrogates of BAY 12-9566S Zucker, S G Eckhardt, E K Rowinsky
Investigational New Drugs|April 9, 2001
Phase II study of 4-ipomeanol, a naturally occurring alkylating furan, in patients with advanced hepatocellular carcinomaS Lakhanpal, R C Donehower, E K Rowinsky
Annals of Internal Medicine|May 1, 1988
Nifedipine and oncologic Raynaud phenomenonA Hantel, E K Rowinsky, R C Donehower
Cancer Treatment Reports|January 1, 1987
Sudden dyspnea occurring 24 hours after mitomycin plus etoposide combination therapyE K Rowinsky, K V Harwood, D S Ettinger
Chest|November 1, 1985
Spontaneous pneumothorax following thoracic irradiationE K Rowinsky, M D Abeloff, M D Wharam
Seminars in Oncology|August 1, 1995
Treatment of metastatic breast cancer with combination paclitaxel/cyclophosphamideM J Kennedy, R C Donehower, E K Rowinsky
Pageof 16